Regulation of dopaminergic transmission and cocaine reward by the Clock gene

Proceedings of the National Academy of Sciences of the United States of America

Volumn 102, Issue 26, 2005, Pages 9377-9381

  McClung, Colleen A ^a   Sidiropoulou, Kyriaki ^b,c   Vitaterna, Martha ^d   Takahashi, Joseph S ^d   White, Francis J ^c   Cooper, Donald C ^a,c   Nestler, Eric J ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF CRETE   (Greece)

^c ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Circadian rhythms; Dopamine; Drug addiction; Tyrosine hydroxylase

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; CASEIN KINASE I; CHOLECYSTOKININ; COCAINE; COMPLEMENTARY DNA; CYTOCHROME; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR 1; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PREPROENKEPHALIN; RECEPTOR SUBUNIT; RNA; SYNAPTOBREVIN; SYNAPTOTAGMIN; TRANSCRIPTION FACTOR CLOCK; TYROSINE 3 MONOOXYGENASE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CIRCADIAN RHYTHM; CLOCK GENE; COCAINE DEPENDENCE; CONDITIONING; DNA MICROARRAY; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; DRUG DEPENDENCE; GENE; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LOCOMOTION; MOUSE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; VENTRAL TEGMENTUM; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; BRAIN; CIRCADIAN RHYTHM; COCAINE; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHYSIOLOGY; HOMOZYGOTE; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, TRANSGENIC; MODELS, NEUROLOGICAL; MUTATION; NEURONS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; PHOSPHORYLATION; POINT MUTATION; REWARD; SUBSTANCE-RELATED DISORDERS; TIME FACTORS; TRANS-ACTIVATORS; TYROSINE 3-MONOOXYGENASE; VENTRAL TEGMENTAL AREA;

EID: 21544442020     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0503584102     Document Type: Article

References (36)

1. Kowatch, R. A., Schnoll, S. S., Knisely, J. S., Green, D. & Elswick, R. K. (1992) J. Addict. Dis. 11, 21-45.
2. Watson, R., Bakos, L., Compton, P. & Gawin, F. (1992) Am. J. Drug Alcohol Abuse 18, 21-28.
3. Johanson, C.E., Roehrs, T., Schuh, K. & Warbasse, L. (1999) Exp. Clin. Psychopharmacol. 7, 338-346.
4. Baird, T. J. & Gauvin, D. (2000) Pharmacol. Biochem. Behav. 65, 289-299.
5. Roberts, D. C., Brebner, K., Vincler, M. & Lynch, W. J. (2002) Drug Alcohol Depend. 67, 291-299.
6. Abarca, C., Albrecht, U. & Spanagel, R. (2002) Proc. Natl. Acad. Sci. USA 99, 9026-9030.
7. Andretic, R., Chaney, S. & Hirsh, J. (1999) Science 285, 1066-1068.
8. Yuferov, V., Kroslak, T., Laforge, K. S., Zhou, Y., Ho, A. & Kreek, M. J. (2003) Synapse 48, 157-169.
9. McClung, C. A. & Nestler, E. J. (2003) Nat. Neurosci. 6, 1208-1215.
10. Wise, R. A. (1987) Pharmacol. Ther. 35, 227-263.
11. Witkovsky, P. (2004) Doc. Ophthalmol. 108, 17-40.
12. Ferguson, S. A., Rowe, S. A., Krupa, M. & Kennaway, D. J. (2000) Brain Res. 858, 284-289.
13. Gekakis, N., Staknis, D., Nguyen, H. B., Davis, F. C., Wilsbacher, L. D., King, D. P., Takahashi, J. S. & Weitz, C. J. (1998) Science 280, 1564-1569.
14. King, D. P., Zhao, Y., Sangoram, A. M., Wilsbacher, L. D., Tanaka, M., Antoch, M. P., Steeves, T. D., Vitaterna, M. H., Kornhauser, J. M. & Lowrey, P. L. (1997) Cell 89, 641-653.
15. Rahman, Z., Schwarz, J., Gold, S. J., Zachariou, V., Wein, M. N., Choi, K. H., Kovoor, A., Chen, C. K., DiLeone, R. J., Schwarz, S. C., et al. (2003) Neuron 38, 941-952.
16. Henry D. J., Greene M. A. & White F. J. (1989) Pharmacol. Exp. Ther. 251, 833-839.
17. Paxinos, G. & Franklin, K. B. J. (2001) Mouse Brain In Stereotaxic Coordinates (Academic, San Diego).
18. Grace, A. A. & Bunney, B. S. (1983) Neuroscience 10, 333-348.
19. White, F. J. (1996) Annu. Rev. Neurosci. 19, 405-436.
20. Grace, A. A. & Bunney, B. S. (1984) J. Neurosci. 4, 2877-2890.
21. Gold, S. J., Han, M. H., Herman, A. E., Ni, Y. G., Pudiak, C. M., Aghajanian, G. K., Liu, R. J., Potts, B. W., Mumby, S. M. & Nestler, E. J. (2003) Eur. J. Neurosci. 17, 971-980.
22. Marinelli, M. & White, F. J. (2000) J. Neurosci. 20, 8876-8885.
23. Witkovsky, P., Veisenberger, E., Haycock, J. W., Akopian, A., Garcia-Espana, A. & Meller, E. (2004) J. Neurosci. 24, 4242-4249.
24. Wise, R. A. & Hoffman, D. C. (1992) Synapse 10, 247-263.
25. Saal, D., Dong, Y., Bonci, A. & Malenka, R. C. (2003) Neuron 37, 577-582.
26. Reppert, S. M. & Weaver, D. R. (2001) Annu. Rev. Physiol. 63, 647-676.
27. Cooper, D. C. (2002) Neurochem. Int. 41, 333-340.
28. Weber, M., Lauterburg, T., Tobler, I. & Burgunder, J. M. (2004) Neurosci. Lett. 358, 17-20.
29. Yoon, S. O. & Chikaraishi, D. M. (1994) J. Biol. Chem. 269, 18453-18462.
30. Komendantov, A. O., Komendantova, O. G., Johnson, S. W. & Canavier, C. C. (2004) J. Neurophysiol. 91, 346-357.
31. Okada, H., Matsushita, N., Kobayashi, K. & Kobayashi, K. (2004) J. Neurochem. 89, 7-14.
32. Steiger, J. L. & Russek, S. J. (2004) Pharmacol. Ther. 101, 259-281.
33. Ning, K., Li, L., Liao, M., Liu, B., Mielke, J. G., Chen, Y., Duan, Y., El-Hayek, Y. H. & Wan, Q. (2004) Nat. Neurosci. 7, 489-490.
34. Robbins, J. (2001) Pharmacol. Ther. 90, 1-19.
35. Carlezon, W. A., Jr., & Nestler, E. J. (2002) Trends Neurosci. 25, 610-615.
36. Thomas, M. J. & Malenka, R. C. (2003) Philos. Trans. R. Soc. London B 358, 815-819.